ARIC Publications
Racial disparity in long-term mortality rate after hospitalization for myocardial infarction: the Atherosclerosis Risk in Communities study." Am Heart J. 2003;146(3):459-64.
"Racial Disparities in Risks of Stroke." N Engl J Med. 2017;376(21):2089-2090.
"Racial disparities in CHD mortality from 1968-1992 in the state economic areas surrounding the ARIC study communities. Atherosclerosis Risk in Communities." Ann Epidemiol. 1999;9(8):472-80.
"Racial Differences in Trends and Prognosis of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction: the Atherosclerosis Risk in Communities (ARIC) Surveillance Study." J Racial Ethn Health Disparities. 2022.
"Racial differences in the prevalence of hypertensive retinopathy." Hypertension. 2003;41(5):1086-91.
"Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study." Diabetes Care. 2016;39(2):285-91.
"Racial Differences in Sudden Cardiac Death." Circulation. 2019;139(14):1688-1697.
"Racial differences in risk factors for atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities." Angiology. 1997;48(4):279-90.
"Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based Population." JAMA Cardiol. 2017;2(12):1341-1348.
"Racial differences in periodontal disease and 10-year self-reported tooth loss among late middle-aged and older adults: the dental ARIC study." J Public Health Dent. 2017;77(4):372-382.
"Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study." Circulation. 2020;141(12):957-967.
"Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2014;179(5):576-83.
"Racial differences in glycemic markers: a cross-sectional analysis of community-based data." Ann Intern Med. 2011;154(5):303-9.
"Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study." J Am Heart Assoc. 2015;4(5).
"Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study." JAMA Cardiol. 2016;1(4):433-41.
"Racial differences in association of elevated interleukin-18 levels with type 2 diabetes: the Atherosclerosis Risk in Communities study." Diabetes Care. 2012;35(7):1513-8.
"Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia." Diabetes Care. 2016;39(4):589-95.
"Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction." J Am Geriatr Soc. 2021.
"Racial and regional differences in venous thromboembolism in the United States in 3 cohorts." Circulation. 2014;129(14):1502-9.
"Racial and Ethnic Differences in the Association Between Classical Cardiovascular Risk Factors and Common Carotid Intima-Media Thickness: An Individual Participant Data Meta-Analysis." J Am Heart Assoc. 2022;11(15):e023704.
"Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study." JACC Heart Fail. 2017;5(3):157-165.
"Race-gender differences in the association of trait anger with subclinical carotid artery atherosclerosis: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2007;165(11):1296-304.
"Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2015;101(6):1232-40.
"Race, Serum Potassium, and Associations With ESRD and Mortality." Am J Kidney Dis. 2017;70(2):244-251.
"Race differences in access to health care and disparities in incident chronic kidney disease in the US." Nephrol Dial Transplant. 2011;26(3):899-908.
"Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study." J Am Geriatr Soc. 2020.
"Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study." JACC Heart Fail. 2015;3(5):347-356.
"Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2010;41(3):417-25.
"Race and sex-based disparities associated with carotid endarterectomy in the Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2020;292:10-16.
"Race- and sex-associated differences in rate-adjusted QT, QTpeak, ST elevation and other regional measures of repolarization: the Atherosclerosis Risk in Communities (ARIC) Study." J Electrocardiol. 2014;47(3):342-50.
"Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2016;133(22):2141-8.
"Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure." J Am Coll Cardiol. 2022;79(4):355-368.
"Race and gender differences in the effects of smoking on lung function." Chest. 2000;117(3):764-72.
"Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 1996;16(3):471-8.
"Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects." PLoS One. 2015;10(8):e0132626.
"Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study." Hum Genet. 2007;121(3-4):421-31.
"Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset." Hum Mol Genet. 2014;23(8):1957-63.
"Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation : A Cross-Sectional Study." Ann Intern Med. 2022;175(8):1073-1082.
"Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis." BMJ. 2019;366:l4292.
"Quality of care for heart failure patients hospitalized for any cause." J Am Coll Cardiol. 2014;63(2):123-30.
"Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project." Genomics. 2019;111(4):808-818.
"Quality control and conduct of genome-wide association meta-analyses." Nat Protoc. 2014;9(5):1192-212.
"The QT interval and risk of incident atrial fibrillation." Heart Rhythm. 2013;10(10):1562-8.
"P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2015;169(1):53-61.e1.
"Pulse pressure and age at menopause." BMC Womens Health. 2002;2(1):6.
"Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis." PLoS Med. 2020;17(10):e1003361.
"Pulmonary function and left ventricular mass in African Americans: the Atherosclerosis Risk in Communities (ARIC) study." Echocardiography. 2012;29(2):131-9.
"Pulmonary Function and Blood DNA Methylation: A Multiancestry Epigenome-Wide Association Meta-analysis." Am J Respir Crit Care Med. 2022;206(3):321-336.
"Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity." Nat Genet. 2019;51(7):1191-1192.
"Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2021;329:36-43.
"Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants." Value Health. 2016;19(8):996-1001.
"P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study." Atherosclerosis. 2006;186(1):74-9.
"Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1998;68(3):726-33.
"Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study." J Clin Gastroenterol. 2021;55(8):677-683.
"Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease." JAMA Intern Med. 2016;176(2):238-46.
"Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study)." Am J Cardiol. 2021;161:42-50.
"Proteomic profiling identifies novel proteins for genetic risk of severe COVID-19: the Atherosclerosis Risk in Communities Study." Hum Mol Genet. 2022;31(14):2452-2461.
"Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Diabetologia. 2022.
"Protein-Z and thrombosis." Lancet. 2001;357(9260):900-1.
"Proteins Associated with Risk of Kidney Function Decline in the General Population." J Am Soc Nephrol. 2021;32(9):2291-2302.
"Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution." Nat Genet. 2019;51(3):452-469.
"Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity." Nat Genet. 2018;50(1):26-41.
"Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study." Arterioscler Thromb Vasc Biol. 2002;22(6):1018-22.
"Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study." Cancers (Basel). 2021;13(8).
"Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)." Thromb Res. 2016;139:44-9.
"A prospective study of venous thromboembolism in relation to factor V Leiden and related factors." Blood. 2002;99(8):2720-5.
"Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism." Am J Hematol. 2002;71(4):285-90.
"Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study." J Thromb Haemost. 2003;1(1):88-94.
"Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism." J Thromb Haemost. 2006;4(9):1909-13.
"Prospective study of sickle cell trait and venous thromboembolism incidence." J Thromb Haemost. 2015;13(1):2-9.
"A prospective study of serum metabolites and risk of ischemic stroke." Neurology. 2019;92(16):e1890-e1898.
"Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism." Thromb Haemost. 2007;97(3):493-4.
"Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure." Thromb Res. 2019;182:89-94.
"A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Epidemiol. 2007;165(9):1047-54.
"Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study." Thromb Res. 2015;136(4):781-5.
"A prospective study of migraine history and venous thromboembolism in older adults." Res Pract Thromb Haemost. 2019;3(3):357-363.
"Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1999;100(7):736-42.
"Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:225-230.
"Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 1997;96(4):1102-8.
"Prospective study of fibrinolytic markers and venous thromboembolism." J Clin Epidemiol. 2003;56(6):598-603.
"